This report quantified the potential impacts of select clinical strategies on the cost, duration, and phase transition probability associated with therapeutic complex medical device development stages. The model used data from a variety of sources (public and non-public) and widely accepted economic methods.
Displaying 1 - 7 of 7. 10 per page. Page 1.Advanced Search
Therapeutic Complex Medical Device Development
November 4, 2022
Evaluating the Potential Impacts of Different Clinical Trial Strategies on Drug, Preventive Vaccine, and Therapeutic Complex Medical Device Development
November 4, 2022
This environmental scan, conducted from September 2016 – September 2021, examines the potential impacts of select strategies on the cost, duration, and phase transition probability associated with drug, preventive vaccine, and therapeutic complex medical device development stages.
ASPE Issue Brief
Estimated Cost of Developing a Therapeutic Complex Medical Device in the US
October 3, 2022
This document presents the abstract of this paper, as published in JAMA Network Open. The full text of the article is available at: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2796179 Related Products:
Examination of Clinical Trial Costs and Barriers for Drug Development
July 24, 2014
Pharmaceutical companies conduct clinical trials for many reasons. The most obvious goal of clinical trials is to demonstrate safety and efficacy to gain Food and Drug Administration (FDA) approval. FDA provides guidance to developers about what constitutes acceptable clinical trials and appropriate outcomes.
NIH Clinical Trials for Spanish Consumers
February 5, 2006
Clinical Baseline Assessment Instrument Set
December 31, 1982